Antibiotic management of anaerobic infections.
D000328:Adult; D000693:Anaerobiosis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology; D001442:Bacteroides Infections / Q000188:drug therapy; D001441:Bacteroides fragilis / Q000201:enzymology; D002228:Carbenicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use; D004357:Drug Synergism; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D008660:Metabolism; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D010400:Penicillin G / Q000627:therapeutic use; D010403:Penicillin Resistance; D011817:Rabbits; D001618:beta-Lactamases / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008795:Metronidazole; D004917:Erythromycin; D002701:Chloramphenicol; D001618:beta-Lactamases; D002228:Carbenicillin; D010400:Penicillin G